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Objectives: Reoperative coronary artery bypass grafting presents unique chal-
lenges for myocardial preservation. The purpose of this study was to compare
oxygenated blood cardioplegia with oxygenated crystalloid cardioplegia during
reoperative coronary artery bypass grafting using transesophageal echocardi-
ography to assess regional wall motion of the left ventricle before and after
cardiopulmonary bypass. Methods: Sixty-one patients undergoing reoperative
coronary artery bypass grafting were prospectively randomized to receive
oxygenated blood cardioplegia or oxygenated crystalloid cardioplegia delivered
with a combined antegrade-retrograde technique. Transgastric short axis
views of the left ventricle were made with transesophageal echocardiography
during the operation before cardiopulmonary bypass and immediately after
cardiopulmonary bypass. Regional wall motion was graded by a blinded
observer, and before cardiopulmonary bypass scores were compared with after
cardiopulmonary bypass scores. Results: No significant differences were found
in the change in regional wall motion score from before cardiopulmonary
bypass to after cardiopulmonary bypass between the blood and crystalloid
cardioplegia groups. Conclusions: This study found blood and crystalloid
cardioplegia to be equally efficacious for myocardial preservation during
reoperative coronary artery bypass grafting. (J Thorac Cardiovasc Surg 1998;
115:1166-71)
The number of long-term survivors of coronaryartery bypass operation has steadily increased
since the procedure was first performed almost 30
years ago, and as a consequence, more and more
patients are undergoing reoperative coronary artery
bypass grafting (rCABG). Numerous reports have
documented the increased risk of rCABG in terms
of mortality and complications compared with pri-
mary CABG.1-3 The presence of high-grade obstruc-
tions in the native coronary vessels and previously
performed vein grafts, patent internal thoracic ar-
tery bypass grafts, and pericardial adhesions create
unique challenges for cardioplegia delivery and
myocardial preservation in this population. Ad-
vances in myocardial preservation techniques such
as blood-containing cardioplegia solutions and ret-
rograde delivery through selective cannulation of
the coronary sinus have been used for rCABG, and
combined antegrade-retrograde cardioplegia ad-
ministration has been put forth as the preferred
mode of myocardial preservation for this group.4
Nonetheless, it remains to be demonstrated whether
blood or crystalloid cardioplegia solution is prefer-
able for these often technically challenging patients.
Although studies comparing these solutions have
been conducted,5-7 none have addressed this issue
specifically for rCABG by use of a combined deliv-
ery technique. In this study we compared oxygen-
ated blood cardioplegia and oxygenated crystalloid
cardioplegia in patients for rCABG, both adminis-
tered by means of a combined antegrade-retrograde
delivery technique. We assessed the quality of myo-
cardial preservation by evaluating and comparing
regional wall motion of the left ventricle (LV) with
transesophageal echocardiography (TEE) during
operation before and after cardiopulmonary bypass
(CPB).
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Patients and methods
With approval of the Human Investigation Committee
and informed consent, 61 consecutive patients undergoing
rCABG by a single surgeon (E.L.J.) were prospectively
randomized to receive oxygenated blood cardioplegia or
oxygenated crystalloid cardioplegia delivered with an an-
tegrade-retrograde technique described in detail below.
After induction of anesthesia, a 5.0 MHZ TEE transducer
(Hewlett-Packard, Andover, Mass.) was placed through
the esophagus into the stomach. Transgastric short-axis
(TGSAX) views of the LV at the midpapillary level were
made during operation before CPB (preCPB) and imme-
diately after CPB (offCPB) when the venous return tubing
was completely clamped and images recorded on 1⁄2-inch
VHS video tape. The images were evaluated retrospec-
tively in random order by an observer (J.S.S.) blinded to
patient identification and type of cardioplegia. The TG-
SAX views of the LV were divided into six segments (Fig.
1). Wall motion was evaluated visually for each segment,
and the regional wall motion score (RWMS) was graded
as follows: 0 5 normal, 1 5 mild hypokinesis, 2 5 severe
hypokinesis, 3 5 akinesis, 4 5 dyskinesis. The preCPB
RWMS of each segment was compared with the offCPB
RWMS, and the number of segments with worse function
offCPB was tabulated for each patient. Analysis 1 defined
worse function as an increase in RWMS by 1 or more
grades, and analysis 2 as an increase in RWMS of 2 or
more grades.
Cardioplegia technique
All patients were cooled on CPB to 25° C. Blood
cardioplegia solution was 4 parts blood withdrawn after
passing through the pump oxygenator to 1 part standard
crystalloid cardioplegia solution (Plegisol) with supple-
mental potassium (K1) to achieve a final concentration
of 18 mEq/L.8 The PO2 of the oxygenated blood was
kept between 200 and 300 mm Hg on CPB. Crystalloid
cardioplegia solution was a standard cardioplegia solu-
tion (Plegisol) with 18 mEq/L K1. This was oxygenated
by bubbling 100% oxygen through the solution as it
circulated in the cooling coil. Studies of this technique
have shown the oxygen content to be about 4 ml/100 ml
of solution.9 Both cardioplegia solutions were adminis-
tered in the same manner: an initial dose of 600 ml was
delivered antegrade through a cannula in the ascending
aorta on aortic crossclamp application immediately
followed by 600 ml delivered retrograde through a
self-inflating coronary sinus cannula (Research Medi-
cal, Inc., Midvale, Utah). Subsequent infusions of 200
ml were given retrograde every 20 minutes until cross-
clamp removal. A total of 100 ml of cardioplegia
solution was infused into each vein graft on completion
of the distal anastomosis. All distal and proximal anas-
tomoses were performed during a single aortic cross-
clamp period. Distal anastomoses were performed in a
sequence moving in a counterclockwise direction from
the right coronary artery to the posterior descending
artery to the LV branch artery to the obtuse marginal
artery to the diagonal artery and finally to the left
anterior descending artery.
Statistical analysis
The randomization of patients was performed accord-
ing to a random permuted blocks design, with the block
size varying at random.10 The randomization assignments
were provided to the investigator in sealed envelopes with
the patient identification number printed on the outside.
For the consecutive patients, the randomization envelopes
were opened once the patient was in the operating room,
and only then was the indicated type of cardioplegia set
up. The number of segments with increase of RWMS after
CPB was the primary outcome variable. The comparison
between the two types of cardioplegia was performed
using the Fisher’s exact test,11 in which the primary
outcome was considered a categorical variable. For other
comparisons, continuous data were displayed as a mean 6
standard deviation. Chi-square or Fisher’s exact test was
used to determine significance of differences for categor-
ical variables and t test or Wilcoxon two-sample test for
continuous variables.11 All test were two-tailed.
Results
Thirty-one patients were assigned to blood car-
dioplegia and 30 patients were assigned to oxygen-
ated crystalloid cardioplegia. No significant differ-
ences were observed between the two groups in age,
sex, history of congestive heart failure, congestive
heart failure class, angina class, history of myocar-
dial infarction, severity of coronary artery disease,
or preoperative ejection fraction (Table I). Signifi-
cantly more patients in the oxygenated crystalloid
cardioplegia group were diabetic (11 vs 4; p 5
0.035). Preoperative characteristics were obtained
from the hospital record, and complete information
Fig. 1. Diagram of the six segment model used for the
regional wall motion analysis of the TEE transgastric
short axis views of the LV. LV, Left ventricle; RV, right
ventricle; AS, anteroseptal segment; Ant, anterior seg-
ment; Lat, lateral segment; Post, posterior segment; Inf,
inferior segment; Sep, septal segment.
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was not available for all patients. Thirty patients in
the blood cardioplegia group and 26 patients in the
oxygenated crystalloid cardioplegia group had TEE
images suitable for analysis. No statistically signifi-
cant differences were found in the number of wors-
ening segments between the two groups with either
analysis 1, in which worse function was defined as an
increase in RWMS by 1 or more grades (Fig. 2), or
analysis 2, in which worse function was defined as an
increase in RWMS of 2 or more grades (Fig. 3).
Twenty-three patients in the blood cardioplegia
group and 24 patients in the oxygenated crystalloid
cardioplegia group received infusions of inotropic
and/or vasopressor drugs while being weaned from
CPB (p 5 0.29). Two patients in the blood cardio-
plegia group and four patients in the oxygenated
crystalloid cardioplegia group had a perioperative
myocardial infarction (p 5 0.18). One patient in the
blood cardioplegia group and three patients in the
oxygenated crystalloid cardioplegia group died in
hospital (p 5 0.35). The patient who received blood
cardioplegia died of sepsis and multiple organ sys-
tem failure, and the rest died of cardiac failure. The
revascularization ratio (targets/grafts performed)
was similar for both groups (1.0 6 0.4 for blood
cardioplegia and 1.1 6 0.5 for oxygenated crystalloid
cardioplegia; p 5 0.46), and the mean number of
grafts performed was not significantly different
(3.8 6 0.8 for blood cardioplegia and 3.4 6 1.2 for
oxygenated crystalloid cardioplegia; p 5 0.13).
Mean total CPB time was longer for the oxygenated
crystalloid group (142.7 6 25.2 min for blood car-
dioplegia, 160.7 6 36.5 min for oxygenated crystal-
loid cardioplegia, p 5 0.04). Mean aortic crossclamp
time showed a trend to be longer with blood cardio-
plegia (87.7 6 18.6 min for blood cardioplegia,
78.1 6 23.3 min for oxygenated crystalloid cardio-
plegia; p 5 0.08).
Table I. Preoperative characteristics
Characteristic
Blood cardioplegia
(n 5 31)
Oxygenated crystalloid cardioplegia
(n 5 30)
p Valuen (%) n (%)
Age (yr) n 5 31 n 5 30 0.85
Mean 6 SD 64.1 6 6.9 63.2 6 8.8
Gender n 5 31 n 5 30 0.67
Female 2 (6.5) 3 (10.0)
Male 29 (93.5) 27 (90.0)
History of CHF n 5 28 n 5 28 1.00
No 23 (82.1) 24 (85.7)
Yes 5 (17.9) 4 (14.3)
CHF class n 5 27 n 5 28 1.00
Class I 26 (96.3) 26 (92.9)
Class II 0 (0.0) 1 (3.6)
Class III 1 (3.7) 0 (0.0)
Class IV 0 (0.0) 1 (3.6)
Angina class n 5 25 n 5 27 0.57
No angina 3 (12.0) 2 (7.4)
Class I 1 (4.0) 0 (0.0)
Class II 3 (12.0) 1 (3.7)
Class III 2 (8.0) 4 (14.8)
Class IV 16 (64.0) 20 (74.1)
History of MI n 5 24 n 5 27 0.16
No 10 (41.7) 6 (23.1)
Yes 14 (58.3) 20 (76.9)
No. diseased coronary arteries n 5 31 n 5 30 0.11
One artery 3 (9.7) 1 (3.3)
Two arteries 3 (9.7) 9 (30.0)
Three arteries 25 (80.6) 20 (66.7)
Ejection fraction (%) n 5 20 n 5 16 0.78
Mean 6 SD 49.3 6 8.4 47.3 6 12.5
Diabetes n 5 28 n 5 28 0.035
No 24 (85.7) 17 (60.7)
Yes 4 (14.3) 11 (39.3)
CHF, Congestive heart failure; MI, myocardial infarction.
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Discussion
This study found no difference between the blood
and oxygenated crystalloid cardioplegia groups in
the number of LV segments with worse RWMS
after CPB. The two techniques were equally effec-
tive for myocardial preservation during rCABG as
assessed by this means. The fact that both cardio-
plegia solutions were oxygenated may have tended
to equalize their beneficial effects. It is also possible
that a difference between the effectiveness of the
techniques exists but could not be detected by a
study of this size. Overall, we did not believe any
clinically significant differences were found between
the groups.
The use of RWMS analysis of the LV to measure
the efficacy of myocardial protection in humans has
not been reported per se, but it seems reasonable to
assume that poorly protected portions of the LV
would have a higher RWMS (less thickening) im-
mediately after CPB than those well protected. We
did not include improvement in RWMS in our
analysis because we believed such changes would
more likely be due to the effects of revascularization
or cardiotonic drugs than cardioplegia technique,
which is generally thought of as a means to preserve
rather than improve myocardial function in the
absence of an acute ischemic syndrome. We com-
pared each segment with itself before and after CPB
and assumed that poor myocardial preservation
would result in a higher RWMS and that a tech-
nique providing better protection would result in
fewer segments showing such an increase in RWMS.
We found no such difference between the groups in
this study. Measurement of LV segmental shorten-
ing,12 as well as LV RWMS from two-dimensional
echocardiographic images,13 have been used to as-
sess myocardial protection in animal models. An-
other means of evaluating cardioplegia in humans is
to measure the release of cardiac enzymes, such as
creatine kinase or troponin, but this method does
not discriminate regional from global injury, which
may be of particular concern during rCABG with its
combination of patent and obstructed native vessels
and previously constructed bypass grafts. In addi-
tion, measuring cardiac enzymes may not detect
functional disturbances not resulting in cell death.
Measurement of cardiac output or LV stroke work
and assessment of the need for inotropic drug or
intraaortic balloon pump support after CPB have
also been used to evaluate myocardial protection,
but these parameters are influenced by many factors
in addition to cardioplegia technique, especially as
the time after CPB increases. The more remote
from CPB, the more difficult it is to attribute
differences in cardiac function to cardioplegia be-
cause more and more confounding factors come
into play. We evaluated change in LV RWMS from
baseline before CPB to immediately after CPB to
minimize the influence of factors other than myo-
cardial protection.
This study analyzed only the TGSAX view of the
LV and therefore did not examine the entire LV,
possibly not detecting RWM changes in regions of
the LV not included in this image (i.e., the apex and
Fig. 2. Analysis 1 in which worse function of an LV
segment after CPB was defined as an increase in RWMS
of 1 or more. No significant difference between blood and
crystalloid cardioplegia was found (p 5 0.73). RWMS,
Regional wall motion score; blood, blood cardioplegia;
crystalloid, oxygenated crystalloid cardioplegia.
Fig. 3. Analysis 2 in which worse function of an LV
segment after CPB was defined as an increase in RWMS
of 2 or more. No significant difference between groups 1
and 2 was found (p 5 0.49). RWMS, Regional wall motion
score; blood, blood cardioplegia; crystalloid, oxygenated
crystalloid cardioplegia.
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the base). It is possible that analysis of all the
segments of the ventricle would have led to a
different result. The TGSAX does, however, show
portions of the LV supplied by all three major
coronary arteries. Also, our analysis did not include
the effects of blood and oxygenated crystalloid car-
dioplegia on the right ventricle, which is clinically
important in some patients.
There are causes of changes in RWMS other than
poor myocardial protection during CPB, most nota-
bly regional perfusion abnormalities and the influ-
ence of revascularization. The number of grafts
performed and the revascularization ratio of the
groups were not significantly different, which argues
that this influence was the same in both groups.
Also, randomization should balance out any other
causes of change in RWMS other than cardioplegia
type, including the presence of patent but diseased
bypass grafts or diffuse distal vessel disease. Warm
terminal blood cardioplegic reperfusate is another
technique of myocardial preservation. This was not
used in this study, which was designed to compare
blood cardioplegia with oxygenated crystalloid car-
dioplegia delivered in the same manner. The addi-
tion of a warm blood perfusate would have invali-
dated this comparison, and it is not routinely
performed by the authors.
The oxygenated crystalloid cardioplegia group did
have a higher incidence of diabetes than the blood
cardioplegia group. Studies suggest that the pres-
ence of diabetes does not influence perioperative
mortality or morbidity for CABG patients,14-16 and
one would suspect that the higher incidence of
diabetes in the oxygenated crystalloid cardioplegia
group would do nothing to improve its myocardial
protection and not influence the conclusion that
oxygenated crystalloid cardioplegia is at least as
effective as blood.
Oxygenated crystalloid cardioplegia may offer
some advantages over blood cardioplegia. It pro-
vides a clearer field of vision during performance of
the distal coronary anastomoses. This may be of
even greater importance for rCABG, in which tissue
planes are already obscured by pericardial adhe-
sions from the previous operation. The finding of a
trend toward shorter aortic crossclamp time in the
oxygenated crystalloid cardioplegia group is consis-
tent with this opinion. On the other hand, by
perfusing the coronary veins with red oxygenated
blood, retrograde blood cardioplegia may facilitate
their distinction from the coronary arteries, an
advantage that crystalloid cardioplegia would not
provide. Finally, crystalloid cardioplegia is simpler
to set up and requires less equipment than blood
cardioplegia, an advantage especially in this era of
managed care and cost containment. Loop and
colleagues17 concluded that blood cardioplegia for
CABG resulted in a cost savings of more than $2000
per case caused mainly by decreased morbidity
compared with crystalloid cardioplegia, but their
study was a comparison of retrospectively matched
cohorts, not a prospectively randomized trial, and
consisted mostly of primary CABG cases with a
minority of rCABG. It is interesting that their
crystalloid cardioplegia group had a highly signifi-
cantly shorter aortic crossclamp time than the blood
cardioplegia group.
This study could detect no difference in the
efficacy of myocardial protection provided by oxy-
genated blood or oxygenated crystalloid cardiople-
gia when administered with a combined antegrade-
retrograde technique to rCABG patients and would
support the use of either technique as preferred by
the operator.
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